The Organizations Behind the Fund
Bringing together government, investment expertise, and innovation leadership
The Spain-US Biotech Fund is built on the combined strengths of organizations that share a common vision: accelerating biotechnology innovation through international collaboration. Each organization contributes unique expertise—from government leadership and investment experience to ecosystem development and strategic relationships—creating an integrated platform that connects scientific excellence, capital, and market opportunities across Spain, Boston, and Massachusetts.
Founding Partners
ICEX Spain Trade and Investment is the Spanish government's agency responsible for promoting international business and investment. As the institution behind the Spain-US Biotech Fund, ICEX is leading a long-term strategy to strengthen the connection between Spain's biotechnology ecosystem and Boston and Massachusetts, the world's leading life sciences hub.
Dreavent is a Boston-based biotechnology investment firm with deep expertise in venture investing, company building, and strategic partnerships. As a founding partner of the Spain-US Biotech Fund, Dreavent leads the Fund's investment activities, leveraging its experienced team and extensive network across venture capital, biotechnology, and the pharmaceutical industry to identify and support high-potential investment opportunities.
Richi LifeSciences is the international life sciences initiative of the Richi Foundation, a Boston-based nonprofit that has evolved into a recognized innovation platform and trusted bridge between international innovation ecosystems and Boston. As a founding partner of the Spain-US Biotech Fund, Richi LifeSciences leads the Fund's institutional strategy, government engagement, and ecosystem development.
Government Partners
The Commonwealth of Massachusetts has built the world's leading biotechnology ecosystem through decades of strategic public investment, industry collaboration, and support for research, entrepreneurship, workforce development, and innovation. Since 2008, the state has committed approximately $2.6 billion to strengthening its life sciences sector, reinforcing its position as the global leader in biotechnology. As a government partner, Massachusetts provides the unique innovation environment that enables the Spain-US Biotech Fund and its portfolio companies to grow and succeed.
As the heart of one of the world's leading innovation ecosystems, the City of Boston plays a pivotal role in advancing entrepreneurship, scientific discovery, and global collaboration. Through its commitment to innovation, economic development, and international partnerships, Boston continues to attract world-class talent, investment, and biotechnology companies, making it a strategic partner in the Spain-US Biotech Fund's mission to connect innovation ecosystems across the Atlantic.
Strategic Partners
M&T Bank is a strategic financial institution committed to advancing innovation, entrepreneurship, and economic growth across Massachusetts. Beyond banking, M&T serves as a connector between the public and private sectors, helping attract international companies, investment, and strategic partnerships to the region. As a strategic partner of the Spain-US Biotech Fund, M&T Bank provides financial expertise and banking infrastructure while supporting the Fund's mission to strengthen cross-border investment and long-term collaboration between Spain and the United States.
Syneos Health is one of the world's leading clinical development organizations, with more than 22,000 professionals across over 100 countries and extensive expertise in clinical development, regulatory strategy, and global trial execution. As a strategic partner of the Spain-US Biotech Fund, Syneos Health contributes to the Fund's Translational Unit by helping identify Spanish biotechnology opportunities aligned with pharmaceutical industry needs and by supporting the design of clinical development roadmaps that position portfolio companies for successful partnering and global growth.